Pharma major Cipla has given a final nod to import Moderna's Covid vaccine for restricted emergency use in India, sources say.
COVID 19: Vaccination drives are in full swing. People have thronged the vaccination centres ever since the Centre has regulated free vaccines for 18 years above. While everyone has eyed Covishield, Covaxin, Sputnik V, due to the shortage of vaccines, many new vaccines are coming up to ease the burden. Moderna, an mRNA vaccine is also one of them. Pharma major Cipla has given a final nod to import Moderna’s Covid vaccine for restricted emergency use in India, sources say.
In terms of efficacy, Moderna is said to be 90 per cent effective against Covid.
To make it more convenient government has decided to waive off bridging trials for foreign vaccines if it is cleared for emergency use in countries like the US and if the safety assessment data of the first 100 beneficiaries is submitted before mass rollout.
Cipla, in its application of drug regulators has, referred to the government’s this decision.
Similarly to Pfizer, Moderna is an mRNA vaccine that has fragments of the genetic material known as messenger RNA.
Regarding the working of the vaccine, it can be said that it works by giving cells, temporary instructions to make the coronavirus spike protein. The protein is found on the surface of the COVID-19 virus.
Pfizer will soon be available in Indi as the process of approval is in the final stage, said Pfizer CEO Albert Bourla.
Foreign vaccines’ roll out has been halted over a condition that India waives indemnity from liability in case of an adverse effect.
Indeed vaccine are need of the hour, what is even more alarming right now is the growing cases of Delta Plus variant in India. Already in four states Maharashtra, Kerala, Madhya Pradesh, Rajasthan have been detected and it is being predicted as the reason for the third wave. Yes, Rajasthan is the fourth state where Delta variant has been detected.
A 65-year-old woman from Rajasthan, who recovered from COVID-19 in May and had undergone both doses of vaccination, has tested positive with the variant.